During the past decade, Helgelandssykehuset, Mo i Rana conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helgelandssykehuset, Mo i Rana" #1 collaborator was "South-Eastern Norway Regional Health Authority" with 1 trials as a collaborator and "The Research Council of Norway" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Helgelandssykehuset, Mo i Rana" are "Psoriatic Arthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Helgelandssykehuset, Mo i Rana" in a lesser frequency.

Most popular intervention types in "Helgelandssykehuset, Mo i Rana" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Co-medication: Synthetic DMARDs" (1 trials), "Conventional treat-to-target" (1 trials), "Imaging informed treat-to-target" (1 trials), "Synthetic DMARD(s)" (1 trials) and "TNF inhibitors" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helgelandssykehuset, Mo i Rana" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Helgelandssykehuset, Mo i Rana". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Helgelandssykehuset, Mo i Rana, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helgelandssykehuset, Mo i Rana, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".